Harpoon Therapeutics Inc
(HARP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 31,915 | 23,654 | 17,444 | 5,777 | 4,750 |
| Gross Profit | 31,915 | 23,654 | 17,444 | 5,777 | 4,750 |
| Operating Expenses | 100,240 | 140,405 | 68,775 | 63,983 | 32,474 |
| Operating Income | -68,325 | -116,751 | -51,331 | -58,206 | -27,724 |
| Other Income | 594 | 30 | 1,423 | 2,634 | 358 |
| Pre-tax Income | -67,731 | -116,721 | -49,908 | -55,572 | -27,366 |
| Net Income Continuous | -67,731 | -116,721 | -49,908 | -55,572 | -27,366 |
| Net Income | $-67,731 | $-116,721 | $-49,908 | $-55,572 | $-27,366 |
| EPS Basic Total Ops | -20.40 | -36.20 | -19.90 | -25.60 | -256.50 |
| EPS Basic Continuous Ops | -20.42 | -36.17 | -19.94 | -25.56 | -256.48 |
| EPS Diluted Total Ops | -20.40 | -36.20 | -19.90 | -25.60 | -256.50 |
| EPS Diluted Continuous Ops | -20.42 | -36.17 | -19.94 | -25.56 | -256.48 |
| EPS Diluted Before Non-Recurring Items | -20.40 | -20.70 | -19.90 | -25.50 | -256.50 |
| EBITDA(a) | $-65,574 | $-112,192 | $-48,758 | $-57,847 | $-27,080 |